Peer Review History
| Original SubmissionNovember 18, 2025 |
|---|
|
Surveillance and control efficacy of the Bergerac, France, 2025 chikungunya outbreak PLOS Neglected Tropical Diseases Dear Dr. White, Thank you for submitting your manuscript to PLOS Neglected Tropical Diseases. After careful consideration, we feel that it has merit but does not fully meet PLOS Neglected Tropical Diseases's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript within by March 02 2026. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Md. Kamrujjaman, Ph.D Academic Editor PLOS Neglected Tropical Diseases Amy Morrison Section Editor PLOS Neglected Tropical Diseases Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-4304-636XX Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-1765-0002 Journal Requirements: 1) Please provide an Author Summary. This should appear in your manuscript between the Abstract (if applicable) and the Introduction, and should be 150-200 words long. The aim should be to make your findings accessible to a wide audience that includes both scientists and non-scientists. Sample summaries can be found on our website under Submission Guidelines: https://journals.plos.org/plosntds/s/submission-guidelines#loc-parts-of-a-submission 2) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: https://journals.plos.org/plosntds/s/figures 3) We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list. 4) Some material included in your submission may be copyrighted. According to PLOSu2019s copyright policy, authors who use figures or other material (e.g., graphics, clipart, maps) from another author or copyright holder must demonstrate or obtain permission to publish this material under the Creative Commons Attribution 4.0 International (CC BY 4.0) License used by PLOS journals. Please closely review the details of PLOSu2019s copyright requirements here: PLOS Licenses and Copyright. If you need to request permissions from a copyright holder, you may use PLOS's Copyright Content Permission form. Please respond directly to this email and provide any known details concerning your material's license terms and permissions required for reuse, even if you have not yet obtained copyright permissions or are unsure of your material's copyright compatibility. Once you have responded and addressed all other outstanding technical requirements, you may resubmit your manuscript within Editorial Manager. Potential Copyright Issues: - Figure S1. Please confirm whether you drew the images / clip-art within the figure panels by hand. If you did not draw the images, please provide (a) a link to the source of the images or icons and their license / terms of use; or (b) written permission from the copyright holder to publish the images or icons under our CC BY 4.0 license. Alternatively, you may replace the images with open source alternatives. See these open source resources you may use to replace images / clip-art: - https://commons.wikimedia.org 5) Please amend your detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published. - State the initials, alongside each funding source, of each author to receive each grant. For example: "This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM)." - State what role the funders took in the study. If the funders had no role in your study, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.". If you did not receive any funding for this study, please simply state: u201cThe authors received no specific funding for this work.u201d Reviewers' Comments: Reviewer's Responses to Questions Key Review Criteria Required for Acceptance? As you describe the new analyses required for acceptance, please consider the following: Methods -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? -Is the study design appropriate to address the stated objectives? -Is the population clearly described and appropriate for the hypothesis being tested? -Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? -Were correct statistical analysis used to support conclusions? -Are there concerns about ethical or regulatory requirements being met? Reviewer #1: I feel they have tried their best to analyse their data after the outbreak has occurred. It is not a research project. Perhaps they are trying to do a model. Reviewer #2: The authors used a mathematical model to evaluate the effectiveness of mosquito control activities during a chikungunya outbreak in Bergerac, France. I am not an expert in this modeling, and the applied method needs to be evaluated by an expert in this field. However, the study design the authors used is adequate to address the objectives. Reviewer #3: The material and method require improvement to be clearer. ********** Results -Does the analysis presented match the analysis plan? -Are the results clearly and completely presented? -Are the figures (Tables, Images) of sufficient quality for clarity? Reviewer #1: This is okay. Because they are modelling after something has occurred. If they had read widely they would have noticed that there are proactive methods that have been suggested for vector surveillance especially for dengue Reviewer #2: The results presented correspond to the analysis plan and are clearly and completely presented. The figures are ok! Reviewer #3: The obtained results are very relevant, however the material require revision in order to interpret the results according to the real situation (biology of the species) and not only according to the model analyses. ********** Conclusions -Are the conclusions supported by the data presented? -Are the limitations of analysis clearly described? -Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? -Is public health relevance addressed? Reviewer #1: I feel more in depth analysis could have been carried out. Reviewer #2: The conclusions of the manuscript are supported by the methods applied and the results obtained. Its relevance lies in the need to conduct studies evaluating the effectiveness of mosquito control measures during arbovirus outbreaks. It's also relevant because few studies like this have been conducted. Reviewer #3: The conclusions follow what was presented in the results. ********** Editorial and Data Presentation Modifications? Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”. Reviewer #1: This is not a problem Reviewer #2: 1 - Background - line 44: I would not say "small outbreaks". Outbreaks are outbreaks! 2 - Methods - lines 103 to 105: to inform the case and probable case definitions for chikungunya in the French surveillance system. - line 168: the velocity and direction of the wind could be considered as covariates in the used model? 3 - Results - line 221: I wouldn't say a "substantial effect", instead I would say a "moderate effect". - lines 257 to 267: I think this paragraph would be better in the Discussion item. 4 - Discussion - line 271: I wouldn't say "substantially reduce autochthonous case numbers". I would use 'moderately' instead of 'substantially'. Reviewer #3: (No Response) ********** Summary and General Comments Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed. Reviewer #1: Here I feel that the authors have not read widely. It has already been shown that fogging after cases are reported are not effective. There is no correlation between cases and mosquitoes. It has been established that cases occur lag of one to 2 weeks after infected mosquitoes are found. RCT have been conducted but this has not been quoted. The authors talk about detecting the virus in wastewater. It would be more practical to detect virus in mosquitoes as simple traps can collect the adult mosquitoes. Such studies have been published since 2011. Reviewer #2: (No Response) Reviewer #3: Dear Authors, Regarding the increasing risk of vector-borne diseases to the public health globally, the studies which could offer answers to the numerous questions that about it, are considered highly valuable. The large experience that countries as Italy and France gained through to fight with the autochthonous cases in the last outbreak that they faced with, represent a good source of data and lessons learnt. The manuscript titled “Surveillance and control efficacy of the Bergerac, France, 2025 chikungunya outbreak”is an interesting and very relevant material that is worth of publishing as a solid evidence of mosquito control quality assessment during the outbreak. However, there are issues that need to be addressed before the submitted material is published. First of all, the title could be significantly improved. For example: it is not control efficacy of the Bergerac but it is quality control of mosquito treatment in Bergerac or evaluation of mosquito control etc… Please be specific and precise. Very important issues are: In the material and method section, is very difficult to follow what was done and why the procedure was changed. That should be explained in details. Why did the treatment start delayed? And why so delayed? If the outbreak was detected in June and treatment was carried out two months later, it means that you could have many, many infected mosquitoes flying around. The Ae. albopictus can survive for a long period of time (few months), so if adults avoided adulticiding they could survive the whole given period that you mentioned. And since the larvae were not in a focus, new adults were emerging again and again. The authors were saying that larviciding did not give good effect but the operators did not perform it in the satisfying level as the authors stated. If the larviciding was not done intensively, there were always new adults coming from the water and representing new threat by spreading virus as said above. If the procedure was not identical at the beginning of the treatments and later, we cannot compare these two periods when the treatment was done. Additionally, there is cumulative effect of treatment. If the operators did not intensively treated between June and August, and then treated intensively in August but without treating juveniles, it is clear that why will need longer period to suppress the population. In the M&M should also be explain what data bases were used when the authors took into consideration the biology of the vector. Did you use your own data base? What about biting rates? How was that measured? Or is that estimated? Please give as many as possible details to provide good understanding and reproducibility of this study. Please also find my specific comments: L45 Please add year and author who described the species, when the species is mentioned for the first time in text. L53 When you say highly competent, it is necessary to specify pathogen. Because it is not competent for all pathogens. L57 It is not the level, but the number. Same comment for L64. L60 Instead of “high levels of travel” it would be more suitable to say “high frequency of travelling” L79 The authors said “many” but gave only one citation as a example. There should be give at least 5 citations if you say “many” L96 Please replace “where” with “if” . L115 Please explain the reasons for the gap. It is crucial for readers to understand the whole concept. L119-124 The sentence is too long and difficult to follow. Please simplify and be more specific about what was done. From the written text it sounds like interventions represented combination of adulticiding, suitability of environment, larviciding , presence of vectors… but it is not clear what exactly was carried out. L124 was done instead of were done L125 …there was a risk… L128 Explain “refuge”. L124-131 The part about adulticiding should be specified. It is not clear whether the 150m done around confirmed case? What about 150-300? L136 Why not? L118 Abbreviate the species name. L270 Cases or numbers. Delete one. L408 Twice 2025. Please delete one. ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy.... Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix. After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript. Reproducibility: To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols |
| Revision 1 |
|
Dear Dr Mark White, We are pleased to inform you that your manuscript 'Surveillance and control efficacy of the Bergerac, France, 2025 chikungunya outbreak' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Md. Kamrujjaman, Ph.D Academic Editor PLOS Neglected Tropical Diseases Amy Morrison Section Editor PLOS Neglected Tropical Diseases Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-4304-636XX Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-1765-0002 *********************************************************** p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 16.0px; font: 14.0px Arial; color: #323333; -webkit-text-stroke: #323333}span.s1 {font-kerning: none Reviewer's Responses to Questions Key Review Criteria Required for Acceptance? As you describe the new analyses required for acceptance, please consider the following: Methods -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? -Is the study design appropriate to address the stated objectives? -Is the population clearly described and appropriate for the hypothesis being tested? -Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? -Were correct statistical analysis used to support conclusions? -Are there concerns about ethical or regulatory requirements being met? Reviewer #1: Okay can be accepted Reviewer #2: The authors accepted almost all the recommendations I made and adequately justified those they did not. ********** Results -Does the analysis presented match the analysis plan? -Are the results clearly and completely presented? -Are the figures (Tables, Images) of sufficient quality for clarity? Reviewer #1: can be accepted Reviewer #2: The authors accepted almost all the recommendations I made and adequately justified those they did not. ********** Conclusions -Are the conclusions supported by the data presented? -Are the limitations of analysis clearly described? -Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? -Is public health relevance addressed? Reviewer #1: Well it only applies to Europe Reviewer #2: The authors accepted almost all the recommendations I made and adequately justified those they did not. ********** Editorial and Data Presentation Modifications? Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”. Reviewer #1: accept Reviewer #2: The authors accepted almost all the recommendations I made and adequately justified those they did not. ********** Summary and General Comments Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed. Reviewer #1: accept Reviewer #2: The authors accepted almost all the recommendations I made and adequately justified those they did not. ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy.... Reviewer #1: No Reviewer #2: No |
| Formally Accepted |
|
Dear Dr White, We are delighted to inform you that your manuscript, "Surveillance and control efficacy of the Bergerac, France, 2025 chikungunya outbreak," has been formally accepted for publication in PLOS Neglected Tropical Diseases. We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly. Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .